The rising interest in GLP-1 agonists for metabolic conditions has led to a question about delivery routes : skin-applied devices versus capsules. Traditionally , GLP-1 therapies were only available in https://lawsonzqtu239805.blog-eye.com/41296167/glp-1-transdermal-delivery-systems-vs-tablets-which-right-for-individuals